Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Enzyme-linked Immunosorbent Assay Testing Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence rate of infectious diseases
5.1.1.2. Need for cost-effective diagnostic tools
5.1.1.3. Government support in increasing infrastructure and treatment initiatives
5.1.2. Restraints
5.1.2.1. Lack of infrastructural faciltities
5.1.3. Opportunities
5.1.3.1. Ongoing developments and launches of the ELISA testing
5.1.3.2. Potential growth for low-cost portable ELISA reader based on image analysis
5.1.4. Challenges
5.1.4.1. Complex assay development workflows
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Enzyme-linked Immunosorbent Assay Testing Market, by Test Type
6.1. Introduction
6.2. Competitive ELISA
6.3. Indirect ELISA
6.4. Multiple & Portable ELISA
6.5. Sandwich ELISA

7. Enzyme-linked Immunosorbent Assay Testing Market, by Application
7.1. Introduction
7.2. Cancer
7.3. Immunology
7.4. Infectious Diseases
7.5. Inflammation
7.6. Protein Quantitation

8. Americas Enzyme-linked Immunosorbent Assay Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Enzyme-linked Immunosorbent Assay Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Enzyme-linked Immunosorbent Assay Testing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abcam
12.1.2. Agilent Technologies Inc.
12.1.3. Becton, Dickinson and Company
12.1.4. Bio-Rad Laboratories
12.1.5. Bio-Techne Corporation
12.1.6. bioM?rieux, Inc.
12.1.7. Enzo Life Sciences, Inc.
12.1.8. Eurofins Scientific SE
12.1.9. F. Hoffmann-La Roche AG
12.1.10. Merck KGaA
12.1.11. PerkinElmer
12.1.12. RayBiotech Life Inc.
12.1.13. Shenzhen YHLO Biotech Co., Ltd.
12.1.14. Thermo Fisher Scientific. Inc.
12.1.15. ZEUS Scientific, Inc. by Sebia
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET RESEARCH PROCESS
FIGURE 2. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET DYNAMICS
FIGURE 7. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 8. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 6. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MULTIPLE & PORTABLE ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PROTEIN QUANTITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 24. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 26. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 34. AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 36. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 38. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 40. INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 44. MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 46. PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 48. SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 50. SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. TAIWAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 54. THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 56. VIETNAM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 63. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 65. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 69. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 71. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 75. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 77. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 81. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 83. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 85. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 87. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 91. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 93. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 95. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 103. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 104. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET LICENSE & PRICING